Solara Active Pharma Sciences Limited

₹654.50As of Sun 8 Nov 2026, 12:00 UTC
NSE:SOLARAHealthcare
Country India
PE (Fwd) •••
TSR 8Y CAGR 14.97%
Div yield —
ROE 2.74%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.96
PE TTM 81.96
TSR TTM 9.12%
Mkt cap ₹31.58B
ROIC 6.75%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹780
19.13%
70.89%
Hold 10|10|8|0|4
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
15.80
16.99
16.58
17.44
28.18%
32.95%
16.22%
15.92%
Revenue₹B
2.295
2.404
2.372
2.423
2.50%
4.00%
(0.17%)
3.69%
Peers (US$325.2M)
Cap (US$)
PE
286.1M
—
Capital
TTM
5Y
10Y
Leveragex
1.267
(0.427)
(0.395)
EBIT/Intx
0.661
0.697
0.625
Own earn%
0.25
(54.24)
(50.23)
Sh yield%
29.02
48.56
47.53
Owners
Insiders/Inst%
2.48
57.51
Short interest%
2.50
SBC / revenue%
4.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
11–15
$1 testx
0.0
Incr. ROIC%
2